Hamilton Lane faces short seller scrutiny over accounting practices By Investing.com

Hunterbrook Capital disclosed a short position in Hamilton Lane, arguing that about one-third of the Private Assets Fund’s valuation gains come from "day-one markups" rather than underlying appreciation. The report also says Hamilton Lane’s 2025 fee-structure change lifted fee-related earnings margin from roughly 32% to 59% for the nine months ended December 2025, while excluding stock-based comp. Shares are down 50% from their peak, and the fund saw an estimated $172 million net outflow in March, the largest on record.

Analysis

The core issue is not whether the accounting is legal; it is whether the market will continue to pay public-market multiples for a business whose reported growth is increasingly driven by mark-to-model mechanics rather than realizable economics. That matters because the biggest vulnerability is reflexive: if redemptions rise, secondary purchases slow, markups slow, and fee-related earnings growth can de-rate faster than consensus expects, especially in a model where management and incentive fees are increasingly tied to internal NAV inflation rather than cash realization.

The first-order loser is HLNE, but the second-order loser could be the entire listed private-asset complex that markets as “asset-light, recurring, high-margin.” The article implies a structural shift in how semi-liquid funds monetize, which could pressure valuation premiums for managers with meaningful evergreen exposure if allocators start distinguishing between AUM and truly distributable cash flow. That creates a read-through risk for BX even with no company-specific issue: public investors may reprice the segment on skepticism around fee quality, not just fee growth.

Near term, the key catalyst set is flow data and any follow-on disclosures around redemption pressure, audit scrutiny, or fee definition changes. Over 1-3 months, the stock is vulnerable to multiple compression if the market concludes the 59% margin is optically inflated; over 6-12 months, the bigger risk is fundraising impairment if institutional LPs demand lower marks, longer gates, or more conservative fee constructs. The contrarian angle is that if the company can demonstrate stable net flows and limited mark-to-market reversals through a quarter or two, bears may be forced to cover because the short thesis depends on both accounting skepticism and an actual liquidity event, not just one or the other.

Key Decisions for Investors

• Short HLNE on rallies or buy 1-3 month put spreads; base case is multiple compression before any fundamental revision, with best risk/reward if the name trades up on sympathy with broader alternatives flows.
• Pair trade: short HLNE / long BX for 3-6 months. The trade isolates accounting/fee-quality risk at HLNE while staying invested in the higher-quality alternative manager with stronger disclosure and scale advantages.
• If options liquidity is workable, buy HLNE downside convexity around the next earnings date; the catalyst is not just EPS but any commentary on redemptions, fee methodology, or evergreen inflows. Favor put spreads to reduce theta bleed.
• Avoid chasing a broad short on the entire private-markets group until flows confirm contagion; if BX sells off on sympathy, use it as a hedge leg rather than the primary short because the read-through is sentiment-driven, not balance-sheet driven.